Chemical Compound

Orbifloxacin; 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS Registry Number 113617-63-3
返回搜索 申请报价
Orbifloxacin; 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 结构式
Primary record

Orbifloxacin; 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

库存
774 克
纯度
99.8 %
CAS
113617-63-3

化合物标识与属性

CAS
113617-63-3
PubChem CID
60605
SMILES
C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)F)C(=O)C(=CN3C4CC4)C(=O)O)F
Canonical SMILES
C[C@@H]1CN(c2c(F)c(F)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1

名称与同义词

  • ORBIFLOXACIN
  • Orbax
  • 113617-63-3
  • orbifloxacine
  • orbifloxacino
  • orbifloxacinum
  • Marufloxacin
  • Posatex
  • Orbax Tablets
  • Orbifloxacin CRS
  • Orbifloxacin [INN]
  • Orbax (veterinary)
  • Orbifloxacin (Standard)
  • RefChem:57814
  • SpecPlus_000366
  • AC1L1TKW
  • Orbifloxacin (USP/INN)
  • ORBIFLOXACIN [MI]
  • DTXSID7046201
  • Orbax [veterinary] (TN)
  • ORBIFLOXACIN [JAN]
  • Orbifloxacin [USP:INN:BAN]
  • C19H20F3N3O3
  • Orbifloxacin impurity mixture
  • MFCD00864858
  • ORBIFLOXACIN [MART.]
  • UNII-660932TPY6
  • MLS000766847
  • MLS001216436
  • DivK1c_006462
  • NSC-758614
  • ORBIFLOXACIN [USP-RS]
  • SCHEMBL125116
  • QIPQASLPWJVQMH-DTORHVGOSA-N
  • AC1Q4N66
  • CHEMBL295433
  • orb1310751
  • 660932TPY6
  • DTXCID5026201
  • SCHEMBL29420860
  • CTK8E6826
  • GTPL13671
  • HY-B0915R
  • KBio1_001406
  • KS-00000XTC
  • MSK5743
  • ORBIFLOXACIN [GREEN BOOK]
  • Orbifloxacin impurity mixture CRS
  • CHEBI:183823
  • DTXCID901777786
  • HMS2875G03
  • HMS3264M13
  • Pharmakon1600-01503711
  • ORBIFLOXACIN [USP IMPURITY]
  • BCP18829
  • CID60605
  • HY-B0915
  • RKL10078
  • ZINC3882891
  • ORBIFLOXACIN [USP MONOGRAPH]
  • Tox21_111867
  • CID:60605
  • MSK5743-100D
  • MSK5743-100M
  • NCGC00160518-01
  • NSC758614
  • s4150
  • AKOS015969739
  • Tox21_111867_1
  • AO40692
  • AT-4526
  • C19-H20-F3-N3-O3
  • CCG-213832
  • CP 104354
  • CP-104354
  • CS-4384
  • DB11443
  • KS-5013
  • NSC 758614
  • RTR-002619
  • Orbifloxacin, 99% - 100MG 100mg
  • NCGC00160518-02
  • NCGC00160518-03
  • NCGC00160518-04
  • 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, rel-
  • AN-33360
  • I546
  • SC-43972
  • SMR000544203
  • SY066864
  • Orbifloxacin Solution in DMSO, 100ug/mL
  • SBI-0207085.P001
  • SID:445468634
  • J323.323E
  • TR-002619
  • B1802
  • CAS-113617-63-3
  • CP-104,354
  • O0516
  • Orbifloxacin Solution in Methanol, 100ug/mL
  • D08299
  • D91881
  • Orbifloxacin for veterinary use [EP monograph]
  • AB00833179_04
  • AB00833179_05
  • Orbifloxacin, VETRANAL(TM), analytical standard
  • A803076
  • C095163
  • SR-01000790054
  • Q7100015
  • SR-01000790054-2
  • SR-01000790054-3
  • BRD-K63001556-001-03-9
  • BRD-K63001556-001-08-8
  • BRD-K63001556-001-09-6
  • 1-(4-BROMOPHENYL)-N-ISOPROPYLMETHANESULFONAMIDE
  • 1-cyclopropyl-7-((3S,5R)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid
  • Orbifloxacin Working Standard (Secondary Reference Standard)
  • 1-Cyclopropyl-7-(cis-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • Orbifloxacin, European Pharmacopoeia (EP) Reference Standard
  • Orbifloxacin, United States Pharmacopeia (USP) Reference Standard
  • 1-Cyclopropyl-5,6,8-trifluoro-1,4-dihydro-7-(cis-3,5-dimethyl-1-piperazinyl)-4-oxo-quinoline-3-carboxylic acid
  • 1-cyclopropyl-7-((3R,5S)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • 1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid
  • 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-quinoline-3-carboxylic acid
  • 1-Cyclopropyl-5,6,8-trifluoro-1,4-dihydro-7-(3beta,5beta-dimethyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid
  • 1-Cyclopropyl-5,6,8-trifluoro-7-(3alpha,5alpha-dimethyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
  • 1-cyclopropyl-5,6,8-trifluoro-7-(cis-3,5-dimethyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
  • 1-cyclopropyl-7-((3S,5R)-3,5-dimethylpiperazin-4-ium-1-yl)-5,6,8-trifluoro-4-oxoquinoline-3-carboxylate
  • 1-Cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
  • 1-CYCLOPROPYL-7-(CIS-3,5-DIMETHYL-1-PIPERAZINYL)-5,6,8-TRIFLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID
  • 1-Cyclopropyl-7-[(3R,5S)-3,5-Dimethylpiperazin-1-yl]-5,6,8-Trifluoro-4-Oxo-Quinoline-3-Carboxylic Acid
  • 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-4-ium-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylate
  • 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-triluoro-4-oxoquinoline-3-carboxylic acid
  • 638-855-2
  • N/A
  • Orbifloxacin; 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid